A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice
about
Overview of mimotopes and related strategies in tumor vaccine development.Immunomodulating antibodies and drugs for the treatment of hematological malignancies.Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.Monoclonal antibody-based immunotherapy for multiple myeloma.Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy.Pidilizumab in the treatment of diffuse large B-cell lymphoma.The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
P2860
Q33389252-85A5931F-8224-48C6-A695-EF64F064BBF9Q37832694-4BFE65CD-16D6-45B1-8C60-105AFBA8B77DQ38014834-B545C35A-7A10-40D7-9C0A-05B55DC5EB03Q38050507-A3B14C01-7265-4B16-AD46-A876660EE4A0Q38219369-E76D2568-9129-4A88-944E-B9D74EC662AFQ38233257-375C4525-DC85-40ED-8DA3-87D08A1E900CQ39705098-CD9196CB-5C5D-43BB-A669-E9AF980C9EFC
P2860
A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
A lymphocyte-activating monocl ...... combined immunodeficient mice
@ast
A lymphocyte-activating monocl ...... combined immunodeficient mice
@en
type
label
A lymphocyte-activating monocl ...... combined immunodeficient mice
@ast
A lymphocyte-activating monocl ...... combined immunodeficient mice
@en
prefLabel
A lymphocyte-activating monocl ...... combined immunodeficient mice
@ast
A lymphocyte-activating monocl ...... combined immunodeficient mice
@en
P2093
P2860
P356
P1476
A lymphocyte-activating monocl ...... combined immunodeficient mice
@en
P2093
P2860
P304
P356
10.1073/PNAS.94.11.5756
P407
P577
1997-05-01T00:00:00Z